GSK-BTX111413

Study Sponsor: GSK

Study Title

Evaluation of GSK Biologicals’ Boostrix® vaccine when compared with Decavac™ in adults aged 65 years or older.

Medicine or Vaccine (generic name)

Combined Reduced Antigen Content Diphtheria, Tetanus, Acellular Pertussis Vaccine

Sponsor Identification Number

BTX111413

Trial Registry Identification Number(#'s)

NCT00835237

Medical Condition

Acellular pertussis; Diphtheria; Tetanus

Phase

Phase 3

Link to study details on the GSK Clinical Study Register

Link to study details on ClinicalTrials.gov (if available)

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

May 2013